Comparison of passive targeted delivery of inorganic and organic nanocarriers among different types of tumors

IF 4.2 2区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Nanomedicine : nanotechnology, biology, and medicine Pub Date : 2024-05-09 DOI:10.1016/j.nano.2024.102753
Alisa S. Postovalova M.Sc , Yulia A. Tishchenko B.Sc , Maria S. Istomina M.Sc , Timofey E. Karpov M.Sc , Sergei A. Shipilovskikh Ph.D , Daria Akhmetova M.Sc , Anna Rogova M.Sc , Nina V. Gavrilova M.Sc , Alexander S. Timin Ph.D
{"title":"Comparison of passive targeted delivery of inorganic and organic nanocarriers among different types of tumors","authors":"Alisa S. Postovalova M.Sc ,&nbsp;Yulia A. Tishchenko B.Sc ,&nbsp;Maria S. Istomina M.Sc ,&nbsp;Timofey E. Karpov M.Sc ,&nbsp;Sergei A. Shipilovskikh Ph.D ,&nbsp;Daria Akhmetova M.Sc ,&nbsp;Anna Rogova M.Sc ,&nbsp;Nina V. Gavrilova M.Sc ,&nbsp;Alexander S. Timin Ph.D","doi":"10.1016/j.nano.2024.102753","DOIUrl":null,"url":null,"abstract":"<div><p>In this study, we have considered four types of nanoparticles (NPs): polylactic acid (PLA), gold (Au), calcium carbonate (CaCO<sub>3</sub>), and silica (SiO<sub>2</sub>) with similar sizes (TEM: 50–110 nm and DLS: 110–140 nm) to examine their passive accumulation in three different tumors: colon (CT26), melanoma (B16-F10), and breast (4T1) cancers. Our results demonstrate that each tumor model showed a different accumulation of NPs, in the following order: CT26 &gt; B16-F10 &gt; 4T1. The Au and PLA NPs were evidently characterized by a higher delivery efficiency in case of CT26 tumors compared to CaCO<sub>3</sub> and SiO<sub>2</sub> NPs. The Au NPs demonstrated the highest accumulation in B16-F10 cells compared to other NPs. These results were verified using SPECT, <em>ex vivo</em> fluorescence bioimaging, direct radiometry and histological analysis. Thus, this work contributes to new knowledge in passive tumor targeting of NPs and can be used for the development of new strategies for delivery of bioactive compounds.</p></div>","PeriodicalId":19050,"journal":{"name":"Nanomedicine : nanotechnology, biology, and medicine","volume":"59 ","pages":"Article 102753"},"PeriodicalIF":4.2000,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine : nanotechnology, biology, and medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1549963424000224","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

In this study, we have considered four types of nanoparticles (NPs): polylactic acid (PLA), gold (Au), calcium carbonate (CaCO3), and silica (SiO2) with similar sizes (TEM: 50–110 nm and DLS: 110–140 nm) to examine their passive accumulation in three different tumors: colon (CT26), melanoma (B16-F10), and breast (4T1) cancers. Our results demonstrate that each tumor model showed a different accumulation of NPs, in the following order: CT26 > B16-F10 > 4T1. The Au and PLA NPs were evidently characterized by a higher delivery efficiency in case of CT26 tumors compared to CaCO3 and SiO2 NPs. The Au NPs demonstrated the highest accumulation in B16-F10 cells compared to other NPs. These results were verified using SPECT, ex vivo fluorescence bioimaging, direct radiometry and histological analysis. Thus, this work contributes to new knowledge in passive tumor targeting of NPs and can be used for the development of new strategies for delivery of bioactive compounds.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
比较无机纳米载体和有机纳米载体在不同类型肿瘤中的被动靶向给药。
在这项研究中,我们考虑了四种类型的纳米粒子(NPs):聚乳酸(PLA)、金(Au)、碳酸钙(CaCO3)和二氧化硅(SiO2),它们具有相似的尺寸(TEM:50-110 nm,DLS:110-140 nm),研究了它们在三种不同肿瘤(结肠癌(CT26)、黑色素瘤(B16-F10)和乳腺癌(4T1))中的被动积累。我们的研究结果表明,每种肿瘤模型都表现出不同的 NPs 积累情况,具体顺序如下:CT26 > B16-F10 > 4T1。与 CaCO3 和 SiO2 NPs 相比,Au 和 PLA NPs 在 CT26 肿瘤中的输送效率更高。与其他 NPs 相比,Au NPs 在 B16-F10 细胞中的蓄积量最高。这些结果通过 SPECT、体内外荧光生物成像、直接辐射测量和组织学分析得到了验证。因此,这项工作为 NPs 的被动肿瘤靶向提供了新的知识,可用于开发新的肿瘤递送策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.10
自引率
0.00%
发文量
133
审稿时长
42 days
期刊介绍: The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine. Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.
期刊最新文献
Comparison of cholesterol transport capacity of peptide- and polymer-based lipid Nanodiscs Retraction notice to “In vitro angiogenic performance and in vivo brain targeting of magnetized endothelial progenitor cells for neurorepair therapies” [Nanomedicine: Nanotechnology, Biology and Medicine 10/1 (2014) 225–234] Facile fabrication of nano-bioactive glass functionalized blended hydrogel with nucleus pulposus-derived MSCs to improve regeneration potential in treatment of disc degeneration by in vivo rat model. Micellar curcumol for maintenance therapy of ovarian cancer by activating the FOXO3a Conceptual rationale for the use of chemically modified nanocomposites for active influence on atherosclerosis using the greater omentum model of experimental animals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1